These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 30937276)

  • 21. 2D Copper(II) Metalated Metal-Organic Framework Nanocomplexes for Dual-enhanced Photodynamic Therapy and Amplified Antitumor Immunity.
    Chen Z; Wu Y; Yao Z; Su J; Wang Z; Xia H; Liu S
    ACS Appl Mater Interfaces; 2022 Oct; 14(39):44199-44210. PubMed ID: 36165392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Self-amplifying ROS-sensitive prodrug-based nanodecoy for circumventing immune resistance in chemotherapy-sensitized immunotherapy.
    Zhang J; Sun X; Xu M; Zhao X; Yang C; Li K; Zhao F; Hu H; Qiao M; Chen D; Zhao X
    Acta Biomater; 2022 Sep; 149():307-320. PubMed ID: 35764242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nanomicelle protects the immune activation effects of Paclitaxel and sensitizes tumors to anti-PD-1 Immunotherapy.
    Yang Q; Shi G; Chen X; Lin Y; Cheng L; Jiang Q; Yan X; Jiang M; Li Y; Zhang H; Wang H; Wang Y; Wang Q; Zhang Y; Liu Y; Su X; Dai L; Tang M; Li J; Zhang L; Qian Z; Yu D; Deng H
    Theranostics; 2020; 10(18):8382-8399. PubMed ID: 32724476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxygen and oxaliplatin-loaded nanoparticles combined with photo-sonodynamic inducing enhanced immunogenic cell death in syngeneic mouse models of ovarian cancer.
    Zheng J; Sun J; Chen J; Zhu S; Chen S; Liu Y; Hao L; Wang Z; Chang S
    J Control Release; 2021 Apr; 332():448-459. PubMed ID: 33662456
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A tumor microenvironment-responsive core-shell tecto dendrimer nanoplatform for magnetic resonance imaging-guided and cuproptosis-promoted chemo-chemodynamic therapy.
    Ni C; Ouyang Z; Li G; Liu J; Cao X; Zheng L; Shi X; Guo R
    Acta Biomater; 2023 Jul; 164():474-486. PubMed ID: 37040813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combinational phototherapy and hypoxia-activated chemotherapy favoring antitumor immune responses.
    Ma B; Sheng J; Wang P; Jiang Z; Borrathybay E
    Int J Nanomedicine; 2019; 14():4541-4558. PubMed ID: 31417257
    [No Abstract]   [Full Text] [Related]  

  • 27. Chlorin e6-induced photodynamic effect facilitates immunogenic cell death of lung cancer as a result of oxidative endoplasmic reticulum stress and DNA damage.
    Yu TT; Hu J; Li QR; Peng XC; Xu HZ; Han N; Li LG; Yang XX; Xu X; Yang ZY; Chen H; Chen X; Wang MF; Li TF
    Int Immunopharmacol; 2023 Feb; 115():109661. PubMed ID: 36608440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A NIR-Light-Activated and Lysosomal-Targeted Pt(II) Metallacycle for Highly Potent Evoking of Immunogenic Cell Death that Potentiates Cancer Immunotherapy of Deep-Seated Tumors.
    Li C; Tu L; Xu Y; Li M; Du J; Stang PJ; Sun Y; Sun Y
    Angew Chem Int Ed Engl; 2024 May; ():e202406392. PubMed ID: 38775364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Restoration of the Immunogenicity of Tumor Cells for Enhanced Cancer Therapy via Nanoparticle-Mediated Copper Chaperone Inhibition.
    Ding F; Li F; Tang D; Wang B; Liu J; Mao X; Yin J; Xiao H; Wang J; Liu Z
    Angew Chem Int Ed Engl; 2022 Aug; 61(31):e202203546. PubMed ID: 35642869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD44-specific nanoparticles for redox-triggered reactive oxygen species production and doxorubicin release.
    Lin CW; Lu KY; Wang SY; Sung HW; Mi FL
    Acta Biomater; 2016 Apr; 35():280-92. PubMed ID: 26853764
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor Microenvironment-Activatable Prodrug Vesicles for Nanoenabled Cancer Chemoimmunotherapy Combining Immunogenic Cell Death Induction and CD47 Blockade.
    Zhou F; Feng B; Yu H; Wang D; Wang T; Ma Y; Wang S; Li Y
    Adv Mater; 2019 Apr; 31(14):e1805888. PubMed ID: 30762908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Destruction Of Laser-Induced Phase-Transition Nanoparticles Triggered By Low-Intensity Ultrasound: An Innovative Modality To Enhance The Immunological Treatment Of Ovarian Cancer Cells.
    Xie W; Zhu S; Yang B; Chen C; Chen S; Liu Y; Nie X; Hao L; Wang Z; Sun J; Chang S
    Int J Nanomedicine; 2019; 14():9377-9393. PubMed ID: 31819438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Engineering oxygen-deficient ZrO
    Jiao X; Sun L; Zhang W; Ren J; Zhang L; Cao Y; Xu Z; Kang Y; Xue P
    Biomaterials; 2021 May; 272():120787. PubMed ID: 33819815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chromomycin A
    Florêncio KGD; Edson EA; Fernandes KSDS; Luiz JPM; Pinto FDCL; Pessoa ODL; Cunha FQ; Machado-Neto JA; Wilke DV
    Front Immunol; 2022; 13():941757. PubMed ID: 36439184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Charge reversal yolk-shell liposome co-loaded JQ1 and doxorubicin with high drug loading and optimal ratio for synergistically enhanced tumor chemo-immunotherapy via blockade PD-L1 pathway.
    Liu D; Li K; Gong L; Fu L; Yang D
    Int J Pharm; 2023 Mar; 635():122728. PubMed ID: 36796659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gelatin-encapsulated iron oxide nanoparticles for platinum (IV) prodrug delivery, enzyme-stimulated release and MRI.
    Cheng Z; Dai Y; Kang X; Li C; Huang S; Lian H; Hou Z; Ma P; Lin J
    Biomaterials; 2014 Aug; 35(24):6359-68. PubMed ID: 24816364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Research progress in inducing immunogenic cell death of tumor cells.
    Xie D; Wang Q; Wu G
    Front Immunol; 2022; 13():1017400. PubMed ID: 36466838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mecheliolide elicits ROS-mediated ERS driven immunogenic cell death in hepatocellular carcinoma.
    Xu Z; Xu J; Sun S; Lin W; Li Y; Lu Q; Li F; Yang Z; Lu Y; Liu W
    Redox Biol; 2022 Aug; 54():102351. PubMed ID: 35671636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Iron-based nanoparticles for MR imaging-guided ferroptosis in combination with photodynamic therapy to enhance cancer treatment.
    Chen Q; Ma X; Xie L; Chen W; Xu Z; Song E; Zhu X; Song Y
    Nanoscale; 2021 Mar; 13(9):4855-4870. PubMed ID: 33624647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multimodal immunogenic cancer cell death as a consequence of anticancer cytotoxic treatments.
    Inoue H; Tani K
    Cell Death Differ; 2014 Jan; 21(1):39-49. PubMed ID: 23832118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.